Investigation of saliva, tongue swabs and buccal swabs as alternative specimen types to nasopharyngeal swabs for SARS-CoV-2 testing.


Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
01 2022
Historique:
received: 06 04 2021
revised: 19 10 2021
accepted: 08 12 2021
pubmed: 18 12 2021
medline: 15 1 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

Throughout the ongoing SARS-CoV-2 pandemic, the recommended sample type for initial diagnostic testing for SARS-CoV-2 infection has been a nasopharyngeal swab. Shortages in swabs and difficulties in obtaining nasopharyngeal swabs in certain patient groups has prompted research into alternative specimen types for the diagnosis of COVID-19. The aim of this study was to assess how 'simply collected' saliva along with tongue swabs and buccal swabs preformed as an alternative specimen type for SARS-CoV-2 detection. It was observed that saliva samples allowed for the detection of 85.3% of positive patients, tongue swabs allowed for the detection of 67.6% of positive patients and buccal swabs allowed for detection of 20.8% of positive patients, when compared to nasopharyngeal swabs. From this data, it could be concluded that using simple saliva collection can provide a less invasive and reliable alternative method for the detection of SARS-CoV2 particularly in those patients where invasive sampling is difficult and where regular repeat testing is required.

Identifiants

pubmed: 34920375
pii: S1386-6532(21)00320-6
doi: 10.1016/j.jcv.2021.105053
pmc: PMC8660128
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105053

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Clin Infect Dis. 2021 Nov 2;73(9):e3106-e3109
pubmed: 33075138
Clin Microbiol Infect. 2019 Mar;25(3):372-378
pubmed: 29906597
Lancet Infect Dis. 2020 Apr;20(4):411-412
pubmed: 32105638
Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4
pubmed: 32422408
Emerg Microbes Infect. 2017 Jun 7;6(6):e49
pubmed: 28588283
BMJ. 2020 Oct 23;371:m3862
pubmed: 33097561
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32883744
Clin Microbiol Newsl. 2020 Aug 1;42(15):121-127
pubmed: 32834295
Int J Oral Sci. 2020 Feb 24;12(1):8
pubmed: 32094336

Auteurs

M C Connor (MC)

Regional Virus Laboratory, Royal Vitoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK. Electronic address: mairead.connor@belfasttrust.hscni.net.

M Copeland (M)

Mater Infirmorum Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.

T Curran (T)

Regional Virus Laboratory, Royal Vitoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH